• |
  • |
  • |
  • |
Donate

Product

Integrating an FDA-cleared eye-tracking-based diagnostic device for autism spectrum disorder into clinical practice.

Center:
Fiscal Year:
2026
Contact Information:
Product Description:
We evaluated a brief autism assessment model (BAAM) specifically designed to integrate an FDA-cleared eye-tracking-based diagnostic device for toddlers (16 to 30 months) within a specialty autism diagnostic clinic. Despite the availability and purported efficacy of the device, no published research to date has examined its integration into clinical practice.
Keyword(s):
autism spectrum disorder, assessment, young children, implementation study
Product/Publication Type(s):
Peer-reviewed publications in scholarly journals Published/In Press
Target Audience:
Professionals, Policymakers, Students
Alternative Format:
To Obtain Copies (URL or Email):
COVID-19 Related Data:
N/A